ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

ACO Leaders Meet With Key White House, Hill Aides

March 29, 1985

NIH Releases Digestive Diseases Research Plan

May 1, 2009

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

Susan Sieber, Former NCI Communications Chief, Dead.

January 25, 2002

CALGB Chairman Schilsky To Step Down After 15 Years Leading Cooperative Group.

February 1, 2008

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009